C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
dc.contributor.author | Wang, Yong | |
dc.contributor.author | Dembowsky, Klaus | |
dc.contributor.author | Chevalier, Eric | |
dc.contributor.author | Stüve, Philipp | |
dc.contributor.author | Korf-Klingebiel, Mortimer | |
dc.contributor.author | Lochner, Matthias | |
dc.contributor.author | Napp, L Christian | |
dc.contributor.author | Frank, Heike | |
dc.contributor.author | Brinkmann, Eva | |
dc.contributor.author | Kanwischer, Anna | |
dc.contributor.author | Bauersachs, Johann | |
dc.contributor.author | Gyongyosi, Mariann | |
dc.contributor.author | Sparwasser, Tim | |
dc.contributor.author | Wollert, Kai C | |
dc.date.accessioned | 2019-02-06T14:38:18Z | |
dc.date.available | 2019-02-06T14:38:18Z | |
dc.date.issued | 2019-01-30 | |
dc.identifier.issn | 1524-4539 | |
dc.identifier.pmid | 30696265 | |
dc.identifier.doi | 10.1161/CIRCULATIONAHA.118.036053 | |
dc.identifier.uri | http://hdl.handle.net/10033/621682 | |
dc.description.abstract | Acute myocardial infarction (MI) elicits an inflammatory response that drives tissue repair and adverse cardiac remodeling. Inflammatory cell trafficking after MI is controlled by C X-C motif chemokine ligand 12 (CXCL12) and its receptor, C-X-C motif chemokine receptor 4 (CXCR4). CXCR4 antagonists mobilize inflammatory cells and promote infarct repair, but the cellular mechanisms are unclear. We investigated the therapeutic potential and mode of action of the peptidic macrocycle CXCR4 antagonist POL5551 in mice with reperfused MI. We applied cell depletion and adoptive transfer strategies using lymphocyte-deficient Rag1 knockout mice; DEREG mice, which express a diphtheria toxin receptor-enhanced green fluorescent protein fusion protein under the control of the promoter/enhancer region of the regulatory T (T Intraperitoneal POL5551 injections in wild-type mice (8 mg/kg at 2, 4, 6, and 8 d) enhanced angiogenesis in the infarct border-zone, reduced scar size, and attenuated left ventricular remodeling and contractile dysfunction at 28 d. Treatment effects were absent in splenectomized wild-type mice, Rag1 knockout mice, and T Our data confirm CXCR4 blockade as a promising treatment strategy after MI. We identify dendritic cell-primed splenic T | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippinscott, Williams & Wilkins; American Heart Association | en_US |
dc.rights | Attribution-NonCommercial-ShareAlike 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject | CXCR4 antagonist | en_US |
dc.subject | Regulatory T cells | en_US |
dc.title | C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function. | en_US |
dc.type | Article | en_US |
dc.contributor.department | TWINCORE, Zentrum für experimentelle und klinische Infektionsforschung GmbH,Feodor-Lynen Str. 7, 30625 Hannover, Germany. | en_US |
refterms.dateFOA | 2019-02-06T14:38:19Z | |
dc.source.journaltitle | Circulation |
Files in this item
This item appears in the following Collection(s)
-
publications of the TwinCore unit Infection immunology [80]
Publications of the Twincore Experimentelle Infektionsforschung -
puplications of TWINCORE unit [TC] Admin [44]